Metered Dose Inhalers (MDI’S) for High-Performance Pulmonary Drug Delivery in Assistance to Nanotechnology

Respiratory infections pose a severe danger to public health's morbidity and death on a global scale. Delivery via the lungs can be accomplished using several drug delivery tools, including nebulizers, MDI’s and dry powder inhalers. Metered dosage inhalers are the most intriguing and the clinic...

Full description

Saved in:
Bibliographic Details
Published in:Biosciences, biotechnology research Asia biotechnology research Asia, 2023-06, Vol.20 (2), p.433-447
Main Authors: Barve, Manali Harshal, Shardul, Priti Kiran, Munne, Satish Sundarrao, Bendale, Atul R, Naphade, Vaishali, Pathan, Vasim T., B. Borse, Laxmikant
Format: Article
Language:English
Subjects:
Aerosols
Asthma
Cancer therapies
Chronic obstructive pulmonary disease
Dendrimers
Dosimetry
Drug delivery
Drug delivery systems
Drug dosages
Effectiveness
Inhalers
Lipids
Lung cancer
Micelles
Morbidity
Mortality
Nanoparticles
Nanotechnology
Patients
Pneumonia
Polyethylene glycol
Polymers
Public health
R&D
Research & development
Respiratory therapy
Respiratory tract infection
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c990-64e72e097c6b27b6dc3056c1a490b9557f42fe6cde6a61b228a05c6d7f7094a83
container_end_page 447
container_issue 2
container_start_page 433
container_title Biosciences, biotechnology research Asia
container_volume 20
creator Barve, Manali Harshal
Shardul, Priti Kiran
Munne, Satish Sundarrao
Bendale, Atul R
Naphade, Vaishali
Pathan, Vasim T.
B. Borse, Laxmikant
description Respiratory infections pose a severe danger to public health's morbidity and death on a global scale. Delivery via the lungs can be accomplished using several drug delivery tools, including nebulizers, MDI’s and dry powder inhalers. Metered dosage inhalers are the most intriguing and the clinician's first preference out of all of them. This review emphasized based on metered dose inhalers for the delivery of pulmonary drugs. This study focuses on the provision of various therapies employing lipid nanocarriers, polymeric nanoparticles dendrimers & micelles, among others, using metered dose inhalers, liposomes, solid lipid nanostructures, nanostructured lipid carriers, and other topics were thoroughly explored. The market scenario for different MDI’s as well as information on digital metered dose inhalers is also covered in this review.
doi_str_mv 10.13005/bbra/3100
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2918061631</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2918061631</sourcerecordid><originalsourceid>FETCH-LOGICAL-c990-64e72e097c6b27b6dc3056c1a490b9557f42fe6cde6a61b228a05c6d7f7094a83</originalsourceid><addsrcrecordid>eNotkN1OwjAUgBujiQS58QmaeKMmk9Nua-klYSokoCRyv3TdGYyMFdvNhDtfw9fzSRzg1fnJl_PzEXLL4ImFAPEwy5wehgzggvR4FIuAC-CXpAdKhgHrOtdk4P0WADgokIz1SLXABh3mNLEe6aze6Aqdp_eLZPb7_fPxQAvr6LRcb4Ilui7f6dogXbbVztbaHWji2jVNsCq_sKvKmo69L31zohpL33RtGzSb2lZ2fbghV4WuPA7-Y5-sXp5Xk2kwf3-dTcbzwCgFgYhQcuxuNiLjMhO5CSEWhulIQabiWBYRL1CYHIUWLON8pCE2IpeFBBXpUdgnd-exe2c_W_RNurWtq7uNKVdsBIKJkHXU45kyznrvsEj3rtx1P6UM0pPP9OgzPfoM_wDv1mih</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2918061631</pqid></control><display><type>article</type><title>Metered Dose Inhalers (MDI’S) for High-Performance Pulmonary Drug Delivery in Assistance to Nanotechnology</title><source>Publicly Available Content Database</source><source>Coronavirus Research Database</source><creator>Barve, Manali Harshal ; Shardul, Priti Kiran ; Munne, Satish Sundarrao ; Bendale, Atul R ; Naphade, Vaishali ; Pathan, Vasim T. ; B. Borse, Laxmikant</creator><creatorcontrib>Barve, Manali Harshal ; Shardul, Priti Kiran ; Munne, Satish Sundarrao ; Bendale, Atul R ; Naphade, Vaishali ; Pathan, Vasim T. ; B. Borse, Laxmikant</creatorcontrib><description>Respiratory infections pose a severe danger to public health's morbidity and death on a global scale. Delivery via the lungs can be accomplished using several drug delivery tools, including nebulizers, MDI’s and dry powder inhalers. Metered dosage inhalers are the most intriguing and the clinician's first preference out of all of them. This review emphasized based on metered dose inhalers for the delivery of pulmonary drugs. This study focuses on the provision of various therapies employing lipid nanocarriers, polymeric nanoparticles dendrimers &amp; micelles, among others, using metered dose inhalers, liposomes, solid lipid nanostructures, nanostructured lipid carriers, and other topics were thoroughly explored. The market scenario for different MDI’s as well as information on digital metered dose inhalers is also covered in this review.</description><identifier>ISSN: 0973-1245</identifier><identifier>EISSN: 2456-2602</identifier><identifier>DOI: 10.13005/bbra/3100</identifier><language>eng</language><publisher>Bhopal: Biosciences Biotechnology Research Asia</publisher><subject>Aerosols ; Asthma ; Cancer therapies ; Chronic obstructive pulmonary disease ; Dendrimers ; Dosimetry ; Drug delivery ; Drug delivery systems ; Drug dosages ; Effectiveness ; Inhalers ; Lipids ; Lung cancer ; Micelles ; Morbidity ; Mortality ; Nanoparticles ; Nanotechnology ; Patients ; Pneumonia ; Polyethylene glycol ; Polymers ; Public health ; R&amp;D ; Research &amp; development ; Respiratory therapy ; Respiratory tract infection</subject><ispartof>Biosciences, biotechnology research Asia, 2023-06, Vol.20 (2), p.433-447</ispartof><rights>2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c990-64e72e097c6b27b6dc3056c1a490b9557f42fe6cde6a61b228a05c6d7f7094a83</cites><orcidid>0000-0002-9816-1923 ; 0000-0001-9609-0036 ; 0000-0003-2830-1983 ; 0000-0002-0857-1604 ; 0000-0002-3059-5856</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2918061631/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2918061631?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25752,27923,27924,37011,38515,43894,44589,74283,74997</link.rule.ids></links><search><creatorcontrib>Barve, Manali Harshal</creatorcontrib><creatorcontrib>Shardul, Priti Kiran</creatorcontrib><creatorcontrib>Munne, Satish Sundarrao</creatorcontrib><creatorcontrib>Bendale, Atul R</creatorcontrib><creatorcontrib>Naphade, Vaishali</creatorcontrib><creatorcontrib>Pathan, Vasim T.</creatorcontrib><creatorcontrib>B. Borse, Laxmikant</creatorcontrib><title>Metered Dose Inhalers (MDI’S) for High-Performance Pulmonary Drug Delivery in Assistance to Nanotechnology</title><title>Biosciences, biotechnology research Asia</title><description>Respiratory infections pose a severe danger to public health's morbidity and death on a global scale. Delivery via the lungs can be accomplished using several drug delivery tools, including nebulizers, MDI’s and dry powder inhalers. Metered dosage inhalers are the most intriguing and the clinician's first preference out of all of them. This review emphasized based on metered dose inhalers for the delivery of pulmonary drugs. This study focuses on the provision of various therapies employing lipid nanocarriers, polymeric nanoparticles dendrimers &amp; micelles, among others, using metered dose inhalers, liposomes, solid lipid nanostructures, nanostructured lipid carriers, and other topics were thoroughly explored. The market scenario for different MDI’s as well as information on digital metered dose inhalers is also covered in this review.</description><subject>Aerosols</subject><subject>Asthma</subject><subject>Cancer therapies</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Dendrimers</subject><subject>Dosimetry</subject><subject>Drug delivery</subject><subject>Drug delivery systems</subject><subject>Drug dosages</subject><subject>Effectiveness</subject><subject>Inhalers</subject><subject>Lipids</subject><subject>Lung cancer</subject><subject>Micelles</subject><subject>Morbidity</subject><subject>Mortality</subject><subject>Nanoparticles</subject><subject>Nanotechnology</subject><subject>Patients</subject><subject>Pneumonia</subject><subject>Polyethylene glycol</subject><subject>Polymers</subject><subject>Public health</subject><subject>R&amp;D</subject><subject>Research &amp; development</subject><subject>Respiratory therapy</subject><subject>Respiratory tract infection</subject><issn>0973-1245</issn><issn>2456-2602</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><recordid>eNotkN1OwjAUgBujiQS58QmaeKMmk9Nua-klYSokoCRyv3TdGYyMFdvNhDtfw9fzSRzg1fnJl_PzEXLL4ImFAPEwy5wehgzggvR4FIuAC-CXpAdKhgHrOtdk4P0WADgokIz1SLXABh3mNLEe6aze6Aqdp_eLZPb7_fPxQAvr6LRcb4Ilui7f6dogXbbVztbaHWji2jVNsCq_sKvKmo69L31zohpL33RtGzSb2lZ2fbghV4WuPA7-Y5-sXp5Xk2kwf3-dTcbzwCgFgYhQcuxuNiLjMhO5CSEWhulIQabiWBYRL1CYHIUWLON8pCE2IpeFBBXpUdgnd-exe2c_W_RNurWtq7uNKVdsBIKJkHXU45kyznrvsEj3rtx1P6UM0pPP9OgzPfoM_wDv1mih</recordid><startdate>20230630</startdate><enddate>20230630</enddate><creator>Barve, Manali Harshal</creator><creator>Shardul, Priti Kiran</creator><creator>Munne, Satish Sundarrao</creator><creator>Bendale, Atul R</creator><creator>Naphade, Vaishali</creator><creator>Pathan, Vasim T.</creator><creator>B. Borse, Laxmikant</creator><general>Biosciences Biotechnology Research Asia</general><scope>AAYXX</scope><scope>CITATION</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><orcidid>https://orcid.org/0000-0002-9816-1923</orcidid><orcidid>https://orcid.org/0000-0001-9609-0036</orcidid><orcidid>https://orcid.org/0000-0003-2830-1983</orcidid><orcidid>https://orcid.org/0000-0002-0857-1604</orcidid><orcidid>https://orcid.org/0000-0002-3059-5856</orcidid></search><sort><creationdate>20230630</creationdate><title>Metered Dose Inhalers (MDI’S) for High-Performance Pulmonary Drug Delivery in Assistance to Nanotechnology</title><author>Barve, Manali Harshal ; Shardul, Priti Kiran ; Munne, Satish Sundarrao ; Bendale, Atul R ; Naphade, Vaishali ; Pathan, Vasim T. ; B. Borse, Laxmikant</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c990-64e72e097c6b27b6dc3056c1a490b9557f42fe6cde6a61b228a05c6d7f7094a83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Aerosols</topic><topic>Asthma</topic><topic>Cancer therapies</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Dendrimers</topic><topic>Dosimetry</topic><topic>Drug delivery</topic><topic>Drug delivery systems</topic><topic>Drug dosages</topic><topic>Effectiveness</topic><topic>Inhalers</topic><topic>Lipids</topic><topic>Lung cancer</topic><topic>Micelles</topic><topic>Morbidity</topic><topic>Mortality</topic><topic>Nanoparticles</topic><topic>Nanotechnology</topic><topic>Patients</topic><topic>Pneumonia</topic><topic>Polyethylene glycol</topic><topic>Polymers</topic><topic>Public health</topic><topic>R&amp;D</topic><topic>Research &amp; development</topic><topic>Respiratory therapy</topic><topic>Respiratory tract infection</topic><toplevel>online_resources</toplevel><creatorcontrib>Barve, Manali Harshal</creatorcontrib><creatorcontrib>Shardul, Priti Kiran</creatorcontrib><creatorcontrib>Munne, Satish Sundarrao</creatorcontrib><creatorcontrib>Bendale, Atul R</creatorcontrib><creatorcontrib>Naphade, Vaishali</creatorcontrib><creatorcontrib>Pathan, Vasim T.</creatorcontrib><creatorcontrib>B. Borse, Laxmikant</creatorcontrib><collection>CrossRef</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Biological Science Database</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Biosciences, biotechnology research Asia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barve, Manali Harshal</au><au>Shardul, Priti Kiran</au><au>Munne, Satish Sundarrao</au><au>Bendale, Atul R</au><au>Naphade, Vaishali</au><au>Pathan, Vasim T.</au><au>B. Borse, Laxmikant</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metered Dose Inhalers (MDI’S) for High-Performance Pulmonary Drug Delivery in Assistance to Nanotechnology</atitle><jtitle>Biosciences, biotechnology research Asia</jtitle><date>2023-06-30</date><risdate>2023</risdate><volume>20</volume><issue>2</issue><spage>433</spage><epage>447</epage><pages>433-447</pages><issn>0973-1245</issn><eissn>2456-2602</eissn><abstract>Respiratory infections pose a severe danger to public health's morbidity and death on a global scale. Delivery via the lungs can be accomplished using several drug delivery tools, including nebulizers, MDI’s and dry powder inhalers. Metered dosage inhalers are the most intriguing and the clinician's first preference out of all of them. This review emphasized based on metered dose inhalers for the delivery of pulmonary drugs. This study focuses on the provision of various therapies employing lipid nanocarriers, polymeric nanoparticles dendrimers &amp; micelles, among others, using metered dose inhalers, liposomes, solid lipid nanostructures, nanostructured lipid carriers, and other topics were thoroughly explored. The market scenario for different MDI’s as well as information on digital metered dose inhalers is also covered in this review.</abstract><cop>Bhopal</cop><pub>Biosciences Biotechnology Research Asia</pub><doi>10.13005/bbra/3100</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0002-9816-1923</orcidid><orcidid>https://orcid.org/0000-0001-9609-0036</orcidid><orcidid>https://orcid.org/0000-0003-2830-1983</orcidid><orcidid>https://orcid.org/0000-0002-0857-1604</orcidid><orcidid>https://orcid.org/0000-0002-3059-5856</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0973-1245
ispartof Biosciences, biotechnology research Asia, 2023-06, Vol.20 (2), p.433-447
issn 0973-1245
2456-2602
language eng
recordid cdi_proquest_journals_2918061631
source Publicly Available Content Database; Coronavirus Research Database
subjects Aerosols
Asthma
Cancer therapies
Chronic obstructive pulmonary disease
Dendrimers
Dosimetry
Drug delivery
Drug delivery systems
Drug dosages
Effectiveness
Inhalers
Lipids
Lung cancer
Micelles
Morbidity
Mortality
Nanoparticles
Nanotechnology
Patients
Pneumonia
Polyethylene glycol
Polymers
Public health
R&D
Research & development
Respiratory therapy
Respiratory tract infection
title Metered Dose Inhalers (MDI’S) for High-Performance Pulmonary Drug Delivery in Assistance to Nanotechnology
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T16%3A22%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metered%20Dose%20Inhalers%20(MDI%E2%80%99S)%20for%20High-Performance%20Pulmonary%20Drug%20Delivery%20in%20Assistance%20to%20Nanotechnology&rft.jtitle=Biosciences,%20biotechnology%20research%20Asia&rft.au=Barve,%20Manali%20Harshal&rft.date=2023-06-30&rft.volume=20&rft.issue=2&rft.spage=433&rft.epage=447&rft.pages=433-447&rft.issn=0973-1245&rft.eissn=2456-2602&rft_id=info:doi/10.13005/bbra/3100&rft_dat=%3Cproquest_cross%3E2918061631%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c990-64e72e097c6b27b6dc3056c1a490b9557f42fe6cde6a61b228a05c6d7f7094a83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2918061631&rft_id=info:pmid/&rfr_iscdi=true